Chart Industries, Inc. Weak Guidance Highlights Q4 Results

Chart Industries’ (NASDAQ:GTLS) overall fourth quarter 2013 EPS and awards were mostly in line with expectations; however, we believe this will be overshadowed by lower-than-expected 2014 EPS guidance ($3.10-$3.50 versus consensus $3.67) and more subdued market commentary regarding near-term growth prospects. There was already a somewhat downward bias to 2014 consensus EPS, the more cautious…

Read More

Notable Analyst Updates – Spectranetics, HSBC, Verizon, New Home Company, Real Page

Sprectranetics (NASDAQ:SPNC) rose 10% and touched a 52-week high after the company said late Monday its trial using laser atherectomy to treat patients suffering from peripheral artery disease (PAD) had achieved statistical endpoints. Separately, Stifel Nicolas repeated its Buy recommendation on the stock and raised its price target to $30 from $24. Spectranetics, a maker…

Read More

Midday Gainers: Intermune Doubles; Tekmira Advances to Record High; Diamond Rock Hits 6-Year High

InterMune (NASDAQ:ITMN) more than doubled Tuesday to its highest value since May 2011 after saying data from a phase 3 trial showed its Pirfenidone drug significantly reduced the progression of idiopathic pulmonary fibrosis. Near midday, ITMN had jumped 126.6% at $31.63 per share in recent trading. Earlier it hit $37.22. Also, significant treatment effects were…

Read More

Zulily (NASDAQ:ZU) Posts Stunningly Good Fourth Quarter

Zulily (NASDAQ:ZU) needed to deliver upside to consensus projections in the fourth quarter, and the magnitude of the top- and bottom-line beat was more than adequate.. The doubling of the active customer base year-to-year is encouraging, and the leverage on marketing spending highlights that there is still significant untapped demand. Flow-through to profitability on higher…

Read More

Tech News

Tech Analysis & Market News

Skip to content ↓